NCT00003641 2026-02-25
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Eastern Cooperative Oncology Group
Phase 3 Active not recruiting
Clinical Trials
4 trialsNCT00975520 2024-11-27
RTN2
Melanoma and Skin Cancer Trials Limited
Phase NA Completed
NCT03220009 2018-10-03
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00004196 2014-01-20
Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
University of Alabama at Birmingham
Phase 3 Completed